New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 9, 2014
09:39 EDTWSTAmgen likely plans to use West's SmartDose, says CL King
CL King says a recent investor presentation from Amgen (AMGN) reviewing evolocumab showed a drug administration device that looks identical to West Pharmaceutical's (WST) SmartDose. As such, the firm has a "very high level of confidence" that Amgen will be using West's SmartDose as one of the administration systems for its PCSK9 inhibitor evolocumab. CL King views the development as a "significant positive" for West and reiterates a Strong Buy rating on the stock with a $58 price target. Shares of West Pharmaceutical are up 3% to $45.56 in early trading.
News For WST From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 12, 2015
08:34 EDTWSTWest Pharmaceutical to develop two new R&D Centers
West Pharmaceutical Services announced a multi-year investment as part of the Company's evolving research and development strategy. West will add capabilities to all of its global Packaging Systems R&D facilities, and develop two new R&D Centers of Excellence, one in the Asia Pacific region and one in Europe, to leverage regional capabilities and expertise in parenteral drug packaging. In addition, a significant investment is being made in North America to expand the current R&D center located within the Exton, Pa. headquarters, and to upgrade the St. Petersburg, Fla. facility.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use